EP
CCXI

Eversept Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Eversept Partners’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-40,842
Closed -$2.35M – 73
2020
Q2 		$2.35M Sell
40,842
-539,169
-93% -$29.3M 0.32% 44
2020
Q1 		$23.3M Buy
580,011
+66,822
+13% +$2.84M 5.79% 6
2019
Q4 		$20.3M Buy
+513,189
New +$9.01M 3.58% 9

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Eversept Partners's CCXI Position: Q3 2020 in Review

Eversept Partners sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 40,842 shares — an estimated $2.35M sold.

Eversept Partners first reported a position in CCXI in Q4 2019 and held it in 3 quarters. The position peaked at $23.3M in Q1 2020. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Eversept Partners reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Eversept Partners sold 40,842 ChemoCentryx, Inc. shares in Q3 2020, an estimated $2.35M.
  • Eversept Partners first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 3 quarters.
  • Eversept Partners's ChemoCentryx, Inc. position peaked at $23.3M in Q1 2020.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Eversept Partners's 13F filing for Q3 2020, filed 12 Nov 2020.